Omalizumab (Xolair) in Children with Atopic Dermatitis: A Review Article
Context: Atopic dermatitis is a chronic skin disease in children. The prevalence of eczema is up to 30% in the world. Omalizumab (Xolair) is a monoclonal antibody that blocks the serum IgE. The aim of this study is to review the effect of Xolair in children with atopic dermatitis. Evidence Acquisiti...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Mazandaran University of Medical Sciences,
2018-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|